WO2012009377A3 - Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same - Google Patents

Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same Download PDF

Info

Publication number
WO2012009377A3
WO2012009377A3 PCT/US2011/043747 US2011043747W WO2012009377A3 WO 2012009377 A3 WO2012009377 A3 WO 2012009377A3 US 2011043747 W US2011043747 W US 2011043747W WO 2012009377 A3 WO2012009377 A3 WO 2012009377A3
Authority
WO
WIPO (PCT)
Prior art keywords
cells
substrate
stem cells
target tissues
diseased
Prior art date
Application number
PCT/US2011/043747
Other languages
French (fr)
Other versions
WO2012009377A2 (en
Inventor
Mark Humayun
Ashish Ahuja
Y. C. Tai
David Hinton
Robert Grubbs
Dennis Clegg
Original Assignee
University Of Southern California
California Institute Of Technology
University Of California At Santa Barbara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Southern California, California Institute Of Technology, University Of California At Santa Barbara filed Critical University Of Southern California
Priority to EP19155369.2A priority Critical patent/EP3549617B1/en
Priority to ES11807411T priority patent/ES2725549T3/en
Priority to EP11807411.1A priority patent/EP2593117B1/en
Priority to EP23188169.9A priority patent/EP4245370A3/en
Priority to AU2011279250A priority patent/AU2011279250B2/en
Priority to JP2013519773A priority patent/JP5876045B2/en
Publication of WO2012009377A2 publication Critical patent/WO2012009377A2/en
Publication of WO2012009377A3 publication Critical patent/WO2012009377A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00—Supports or coatings for cell culture characterised by topography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
    • Y10T428/24479—Structurally defined web or sheet [e.g., overall dimension, etc.] including variation in thickness

Abstract

Substrates for cell delivery to target tissues requiring treatment for various diseases that induce cell death, damage or loss of function. The substrates are configured to provide seeded cells, including stem cells, with a structural support that allows interconnection with and transmission of biological signals between the cells and the target tissue. A substrate for cellular therapy to treat diseased or damaged ocular tissue, comprising a non-porous polymer having an apical and basal surface, wherein the substrate is configured to support a population of cells suitable for the treatment of diseased or damaged ocular tissue, and wherein, upon implantation into a subject, the substrate supports the population of cells for a period of time sufficient to treat the diseased or damaged ocular tissue.
PCT/US2011/043747 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same WO2012009377A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP19155369.2A EP3549617B1 (en) 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
ES11807411T ES2725549T3 (en) 2010-07-12 2011-07-12 Biocompatible substrate to facilitate interconnections between stem cells and target tissues and methods to implant it
EP11807411.1A EP2593117B1 (en) 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
EP23188169.9A EP4245370A3 (en) 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
AU2011279250A AU2011279250B2 (en) 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
JP2013519773A JP5876045B2 (en) 2010-07-12 2011-07-12 Biocompatible substrate that promotes interconnection of stem cells and target tissue and method of implanting the same

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36363010P 2010-07-12 2010-07-12
US61/363,630 2010-07-12
US38783010P 2010-09-29 2010-09-29
US61/387,830 2010-09-29
US201161481004P 2011-04-29 2011-04-29
US61/481,004 2011-04-29

Publications (2)

Publication Number Publication Date
WO2012009377A2 WO2012009377A2 (en) 2012-01-19
WO2012009377A3 true WO2012009377A3 (en) 2012-10-04

Family

ID=45470037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/043747 WO2012009377A2 (en) 2010-07-12 2011-07-12 Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same

Country Status (6)

Country Link
US (3) US8808687B2 (en)
EP (3) EP3549617B1 (en)
JP (4) JP5876045B2 (en)
AU (3) AU2011279250B2 (en)
ES (2) ES2963295T3 (en)
WO (1) WO2012009377A2 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012149480A2 (en) 2011-04-29 2012-11-01 University Of Southern California Systems and methods for in vitro and in vivo imaging of cells on a substrate
WO2012009377A2 (en) 2010-07-12 2012-01-19 University Of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
BR112013021514A2 (en) * 2011-02-25 2020-09-29 Riken retinal pigment epithelial cell layer production method
ES2722207T3 (en) 2011-04-29 2019-08-08 Univ Southern California Procedures for cryopreservation of retinal pigment epithelial cells derived from cytoblasts grown on a polymeric substrate
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
CA2837558C (en) 2011-06-02 2018-11-20 Massachusetts Institute Of Technology Modified alginates for cell encapsulation and cell therapy
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
US9850463B2 (en) * 2012-02-01 2017-12-26 The Regents Of The University Of California Methods of culturing retinal pigmented epithelium cells, including xeno-free production, RPE enrichment, and cryopreservation
SG11201406622UA (en) * 2012-04-20 2014-11-27 Agency Science Tech & Res An in vitro method for culturing stem cells
WO2013160907A1 (en) 2012-04-23 2013-10-31 Ghansham Das Agrawal A device for treatment of glaucoma
WO2013163758A1 (en) * 2012-05-01 2013-11-07 Boyd Shelley Romayne Methods for treating and diagnosing blinding eye diseases
US20130317411A1 (en) * 2012-05-23 2013-11-28 Ghansham Das AGARWAL Device for Treatment of Glaucoma
CN113088481A (en) * 2012-08-24 2021-07-09 独立行政法人理化学研究所 Method for producing retinal pigment epithelial cell sheet
US20140243995A1 (en) * 2013-02-28 2014-08-28 The Massachusetts Institute Of Technology Stacked planar sheet tissue engineering scaffolds with 3d structural order
US20140341965A1 (en) * 2013-03-14 2014-11-20 Georgetown University Compositions and Methods Comprising Biodegradable Scaffolds and Retinal Pigment Epithelial Cells
US9781842B2 (en) 2013-08-05 2017-10-03 California Institute Of Technology Long-term packaging for the protection of implant electronics
CN103551040B (en) * 2013-11-15 2015-06-24 中国海洋石油总公司 Online repairing method of NaA molecular sieve membrane
JP2017504311A (en) 2013-12-11 2017-02-09 ファイザー・リミテッドＰｆｉｚｅｒ Ｌｉｍｉｔｅｄ Method for generating retinal pigment epithelial cells
US20170021149A9 (en) * 2014-05-02 2017-01-26 National Institute Of Standards And Technology Biological sampling platform and processes for making and using same
CN112999429B (en) 2014-08-01 2022-07-22 麻省理工学院 Modified alginates for anti-fibrotic materials and uses
AU2016344041B2 (en) * 2015-11-01 2019-11-07 Massachusetts Institute Of Technology Materials with improved properties
KR102428530B1 (en) 2016-05-05 2022-08-02 사우스웨스트 리서치 인스티튜트 3D bioreactor for cell expansion and related applications
US10730983B2 (en) 2016-06-13 2020-08-04 Massachusetts Institute Of Technology Biocompatible coatings and hydrogels for reducing foreign body response and fibrosis
KR20200028391A (en) * 2017-06-12 2020-03-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 Patching composition for cell engraftment
US20200368394A1 (en) * 2017-07-31 2020-11-26 Lineage Therapeutics, Inc. Compositions and methods for restoring or preventing loss of vision caused by disease or traumatic injury
EP3449874A1 (en) * 2017-08-31 2019-03-06 Chandrashekar Balachandran Corneal implant
US11318231B2 (en) 2017-11-06 2022-05-03 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
KR102132807B1 (en) * 2017-12-13 2020-07-13 연세대학교 산학협력단 A stem cell culture composition comprising a copolymer capable of controlling stemness
CA3078869A1 (en) * 2017-12-20 2019-06-27 Philip Morris Products S.A. Improved cell culture device
US11149244B2 (en) 2018-04-04 2021-10-19 Southwest Research Institute Three-dimensional bioreactor for T-cell activation and expansion for immunotherapy
AU2019333301A1 (en) 2018-08-31 2021-02-25 Wisconsin Alumni Research Foundation Generating arterial endothelial cell-seeded vascular grafts
CA3110745A1 (en) 2018-09-07 2020-03-12 University Of Southern California Cryopreservation of cell-seeded substrates and related methods
KR20210064299A (en) * 2018-09-24 2021-06-02 사우스웨스트 리서치 인스티튜트 3D Bioreactor
CN109575338B (en) * 2018-11-19 2021-05-28 暨南大学 Polylactic acid composite membrane with surface modified with ordered chitin whisker layer, and preparation method and application thereof
JP7287032B2 (en) * 2019-03-20 2023-06-06 株式会社リコー SHEET, SHEET LAMINATED PRODUCT, PHARMACEUTICAL, SHEET MANUFACTURING METHOD, AND SHEET LAMINATED MANUFACTURING METHOD
CN110564674B (en) * 2019-09-29 2021-05-11 广东工业大学 Stem cell bottoming working solution and application thereof
WO2021262645A1 (en) * 2020-06-22 2021-12-30 Ohio State Innovation Foundation Redox-responsive nanoparticle compositions for ocular delivery of therapeutics
JPWO2022202652A1 (en) * 2021-03-23 2022-09-29

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060002900A1 (en) * 2002-10-04 2006-01-05 Susanne Binder Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
US20060104957A1 (en) * 2004-11-15 2006-05-18 The Board of Louisiana State University and Agricultural and Mechanical College Bioartificial lacrimal gland
US20060282128A1 (en) * 2005-04-28 2006-12-14 California Institute Of Technology Batch-fabricated flexible intraocular retinal prosthesis system and method for manufacturing the same
US20100068141A1 (en) * 2005-07-27 2010-03-18 University Of Florida Use of heat shock to treat ocular disease
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
US20110004304A1 (en) * 2009-03-20 2011-01-06 Tao Sarah L Culturing retinal cells and tissues

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4047532A (en) 1975-04-21 1977-09-13 Phillips Jack L Vacuum forcep and method of using same
JPS5465377A (en) 1977-11-01 1979-05-25 Tokyo Shibaura Electric Co Vacuum bulb
JPS6045091U (en) 1983-09-07 1985-03-29 株式会社　バンダイ vehicle toy
US4700298A (en) 1984-09-14 1987-10-13 Branko Palcic Dynamic microscope image processing scanner
US4715373A (en) 1985-09-27 1987-12-29 Mazzocco Thomas R Devices for implantation of deformable intraocular lens structures
US5024223A (en) * 1989-08-08 1991-06-18 Chow Alan Y Artificial retina device
FR2668696B1 (en) 1990-11-06 1993-02-19 Ethnor ENDOSCOPIC SURGICAL INSTRUMENT FOR TISSUE ENTRY.
EP0585368B1 (en) 1991-04-25 1997-08-06 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
US6963792B1 (en) 1992-01-21 2005-11-08 Sri International Surgical method
US5688264A (en) * 1992-10-19 1997-11-18 The University Of Miami Laser treatment for retinal detachment
AU5884394A (en) 1993-01-18 1994-08-15 Evotec Biosystems Gmbh Method and device for assessing the suitability of biopolymers
US5908623A (en) 1993-08-12 1999-06-01 Cytotherapeutics, Inc. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US6054142A (en) 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
US6254628B1 (en) 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
CA2216439A1 (en) 1996-09-25 1998-03-25 Derek Van Der Kooy Pharmaceuticals containing retinal stem cells
JP3052895B2 (en) 1997-06-23 2000-06-19 日本電気株式会社 Cytotoxicity test method
CA2307807C (en) 1997-10-23 2008-09-02 Andrea G. Bodnar Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
US6156042A (en) 1997-11-17 2000-12-05 Aramant; Robert B. Retinal tissue implantation instrument
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
WO2000027995A1 (en) 1998-11-09 2000-05-18 Monash University Embryonic stem cells
US6361771B1 (en) 1999-04-06 2002-03-26 Neurotech S.A. ARPE-19 as a platform cell line for encapsulated cell-based delivery
US6103255A (en) 1999-04-16 2000-08-15 Rutgers, The State University Porous polymer scaffolds for tissue engineering
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
US7005252B1 (en) 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
US7439064B2 (en) 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
US20100173410A1 (en) 2000-03-09 2010-07-08 Wicell Research Institute, Inc. Cultivation of Primate Embryonic Stem Cells
US7011828B2 (en) 2000-03-14 2006-03-14 Es Cell International Pte. Ltd. Implanting neural progenitor cells derived for human embryonic stem cells
IL151170A0 (en) 2000-03-14 2003-04-10 Es Cell Int Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
US7250294B2 (en) 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
US20020009743A1 (en) 2000-05-17 2002-01-24 Carpenter Melissa K. Neural progenitor cell populations
AU2001294671A1 (en) 2000-09-25 2002-04-08 The Board Of Trustees Of The University Of Illinois Microfabrication of membranes for the growth of cells
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
JP4267867B2 (en) 2001-05-03 2009-05-27 ラディ・メディカル・システムズ・アクチェボラーグ Wound occlusion element guide device
US6939378B2 (en) 2001-06-01 2005-09-06 The Board Of Trustees Of The Leland Stanford Junior University Microfabricated tissue as a substrate for pigment epithelium transplantation
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
KR100976186B1 (en) 2001-11-21 2010-08-17 아이싸이언스 코포레이션 Ophthalmic microsurgical system
WO2003056019A1 (en) 2001-12-24 2003-07-10 Es Cell International Pte Ltd Method of transducing es cells
US7141369B2 (en) 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
US7653212B2 (en) 2006-05-19 2010-01-26 Universal Electronics Inc. System and method for using image data in connection with configuring a universal controlling device
CA2488429C (en) 2002-06-05 2013-05-07 Benjamin Eithan Reubinoff Generation of neural stem cells from undifferentiated human embryonic stem cells
US6852527B2 (en) 2002-06-06 2005-02-08 Inovyx, Inc. Apparatus and method for the measurement of cells in biological samples
US7272252B2 (en) 2002-06-12 2007-09-18 Clarient, Inc. Automated system for combining bright field and fluorescent microscopy
US7135172B1 (en) 2002-09-04 2006-11-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Bucky paper as a support membrane in retinal cell transplantation
US20050021345A1 (en) * 2003-05-05 2005-01-27 Rotella Carl Jay Webcall
CA2530533C (en) 2003-06-27 2015-02-10 Ethicon, Incorporated Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US7147648B2 (en) 2003-07-08 2006-12-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Device for cutting and holding a cornea during a transplant procedure
US20050106554A1 (en) 2003-11-19 2005-05-19 Palecek Sean P. Cryopreservation of pluripotent stem cells
US7316822B2 (en) 2003-11-26 2008-01-08 Ethicon, Inc. Conformable tissue repair implant capable of injection delivery
CA2852122A1 (en) 2004-01-02 2005-07-28 Advanced Cell Technology, Inc. Novel culture systems for ex vivo development
US7794704B2 (en) 2004-01-23 2010-09-14 Advanced Cell Technology, Inc. Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
EP2929782A1 (en) 2004-01-23 2015-10-14 Ocata Therapeutics, Inc. Improved modalities for the treatment of degenerative diseases of the retina
US20050214345A1 (en) * 2004-02-20 2005-09-29 Theodore Leng Artificial biocompatible material as a support for cells in a retinal implant
US7601525B2 (en) 2004-03-05 2009-10-13 University Of Florida Research Foundation, Inc. Alginate gel scaffold having a plurality of continuous parallel microtubular copper capillaries
WO2006023130A2 (en) * 2004-08-12 2006-03-02 Surmodics, Inc. Biodegradable controlled release bioactive agent delivery device
US7893315B2 (en) 2004-11-04 2011-02-22 Advanced Cell Technology, Inc. Derivation of embryonic stem cells and embryo-derived cells
US7838727B2 (en) 2004-11-04 2010-11-23 Advanced Cell Technology, Inc. Derivation of embryonic stem cells
WO2006055338A2 (en) 2004-11-08 2006-05-26 Chuck Roy S Methods and systems for identifying and isolating stem cells and for observing mitochondrial structure and distribution in living cells
US8597947B2 (en) 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
WO2006070370A2 (en) 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
US7846467B2 (en) 2005-01-13 2010-12-07 Minas Theodore Coroneo Ocular scaffold for stem cell cultivation and methods of use
WO2006106506A2 (en) 2005-04-04 2006-10-12 Technion Research & Development Foundation Ltd. Medical scaffold, methods of fabrication and using thereof
US20060235430A1 (en) 2005-04-15 2006-10-19 Intralens Vision, Inc. Corneal implant injector assembly and methods of use
EP1910516B1 (en) 2005-06-22 2019-06-19 Asterias Biotherapeutics, Inc. Suspension culture of human embryonic stem cells
US7713232B2 (en) 2005-11-04 2010-05-11 Medrad, Inc. System for washing and processing of cells for delivery thereof to tissue
US20070128420A1 (en) 2005-12-07 2007-06-07 Mariam Maghribi Hybrid composite for biological tissue interface devices
JP5247468B2 (en) 2005-12-30 2013-07-24 ニューロテック ユーエスエー， インコーポレイテッド Micronized device for delivery of bioactive molecules and method of use thereof
FR2896022B1 (en) 2006-01-10 2008-04-18 Snr Roulements Sa ROTATING SEAL TRIM AND BEARING BEARING COMPRISING SUCH A TRIM
US7541186B2 (en) 2006-02-22 2009-06-02 University Of Washington Method of generating human retinal progenitors from embryonic stem cells
ITPC20060025A1 (en) 2006-05-15 2007-11-16 Claudio Malacuso SURGICAL INSTRUMENT TO MANIPULATE AND INSERT A CELL LAMINA IN THE EYE, IN PARTICULAR A THIN SUPPORT OF STROMA WITH ENDOTHELIAL CELLS, FOR CORNEAL TRANSPLANT
EP2786701B1 (en) 2006-08-29 2015-12-23 California Institute of Technology Microfabricated implantable wireless pressure sensor for use in biomedical applications and pressure measurement and sensor implantation methods
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US8080593B2 (en) * 2006-11-29 2011-12-20 University Of Southern California Reversible thermoresponsive adhesives for implants
US20080255578A1 (en) 2007-02-09 2008-10-16 Fisher Surgical Corneal endothelial tissue inserter
ES2596707T3 (en) 2007-04-16 2017-01-11 Regentis Biomaterials Ltd. Compositions and methods for frame formation
CN103555654B (en) 2007-04-18 2016-04-20 哈达锡特医学研究服务及发展有限公司 Stem cell-derived retinal pigment epithelium
US20110060232A1 (en) 2007-05-04 2011-03-10 The General Hospital Corporation Retinal flow cytometry
US9862925B2 (en) 2007-10-29 2018-01-09 Hadasit Medical Research Services & Development Limited Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
US20090123992A1 (en) 2007-11-12 2009-05-14 Milton Chin Shape-Shifting Vitrification Device
EP2222159B1 (en) 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
US7914147B2 (en) 2008-03-26 2011-03-29 Image Technologies Corporation Systems and methods for optical detection of lipofuscin concentrations in a subject's eye
WO2009122413A1 (en) 2008-03-31 2009-10-08 Hadasit Medical Research Services & Development Limited Motor neurons developed from stem cells
US20100189338A1 (en) 2008-04-09 2010-07-29 Nexcelom Bioscience Systems and methods for counting cells and biomolecules
GB0806746D0 (en) 2008-04-14 2008-05-14 Ucl Business Plc Membrane
US20090306772A1 (en) 2008-04-18 2009-12-10 The Regents Of The University Of California Ocular Scaffolds and Methods for Subretinal Repair of Bruch's Membrane
WO2009132212A2 (en) 2008-04-25 2009-10-29 The Regents Of The University Of California Device to store and inject corneal graft
US8057483B2 (en) 2009-02-14 2011-11-15 Ocular Transplantation Llc Subretinal implantation instrument
US20100241060A1 (en) 2009-03-18 2010-09-23 Roizman Keith Surgical devices and methods
WO2010135603A2 (en) 2009-05-20 2010-11-25 California Institute Of Technology Method for cancer detection, diagnosis and prognosis
GB201011313D0 (en) 2010-07-05 2010-08-18 Ucl Business Plc Implantation devices, methods and implants
WO2012009377A2 (en) 2010-07-12 2012-01-19 University Of Southern California Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
WO2012149480A2 (en) 2011-04-29 2012-11-01 University Of Southern California Systems and methods for in vitro and in vivo imaging of cells on a substrate
US9810685B2 (en) 2010-10-05 2017-11-07 The Regents Of The University Of California High-throughput platform comprising microtissues perfused with living microvessels
ES2722207T3 (en) 2011-04-29 2019-08-08 Univ Southern California Procedures for cryopreservation of retinal pigment epithelial cells derived from cytoblasts grown on a polymeric substrate
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
US10478206B2 (en) 2011-04-29 2019-11-19 University Of Southern California Instruments and methods for the implantation of cell-seeded substrates
WO2013019714A1 (en) 2011-07-29 2013-02-07 The Trustees Of Columbia University In The City Of New York Mems affinity sensor for continuous monitoring of analytes
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060002900A1 (en) * 2002-10-04 2006-01-05 Susanne Binder Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
US20060104957A1 (en) * 2004-11-15 2006-05-18 The Board of Louisiana State University and Agricultural and Mechanical College Bioartificial lacrimal gland
US20060282128A1 (en) * 2005-04-28 2006-12-14 California Institute Of Technology Batch-fabricated flexible intraocular retinal prosthesis system and method for manufacturing the same
US20100068141A1 (en) * 2005-07-27 2010-03-18 University Of Florida Use of heat shock to treat ocular disease
US20110004304A1 (en) * 2009-03-20 2011-01-06 Tao Sarah L Culturing retinal cells and tissues

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HANNACHI ET AL.: "Cell sheet technology and cell patterning for biofabrication. art 022002", BIOFABRICATION, vol. 1, no. 2, 10 June 2009 (2009-06-10), pages 022002, XP055021652, Retrieved from the Internet <URL:http://iopscience.iop.org/1758-5090/1/2/022002> [retrieved on 20120717] *

Also Published As

Publication number Publication date
JP2013530792A (en) 2013-08-01
US20150147377A1 (en) 2015-05-28
AU2011279250A1 (en) 2013-02-21
EP2593117A2 (en) 2013-05-22
JP6542320B2 (en) 2019-07-10
JP6215977B2 (en) 2017-10-18
US20190151499A1 (en) 2019-05-23
JP7336885B2 (en) 2023-09-01
EP3549617A1 (en) 2019-10-09
US8808687B2 (en) 2014-08-19
AU2011279250B2 (en) 2014-12-04
ES2963295T3 (en) 2024-03-26
US10188769B2 (en) 2019-01-29
JP5876045B2 (en) 2016-03-02
EP2593117A4 (en) 2014-01-15
JP2016104791A (en) 2016-06-09
AU2016204936B2 (en) 2018-03-08
JP2019147020A (en) 2019-09-05
JP2017217530A (en) 2017-12-14
EP3549617B1 (en) 2023-09-13
EP4245370A3 (en) 2023-11-29
EP2593117B1 (en) 2019-03-20
EP4245370A2 (en) 2023-09-20
AU2015200823A1 (en) 2015-03-12
WO2012009377A2 (en) 2012-01-19
AU2016204936A1 (en) 2016-08-04
US11154639B2 (en) 2021-10-26
ES2725549T3 (en) 2019-09-24
US20120009159A1 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
WO2012009377A3 (en) Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
WO2012149468A3 (en) Instruments and methods for the implantation of cell-seeded substrates
EP2702135B1 (en) Method of cryopreservation of stem cell-derived retinal pigment epithelial cells on polymeric substrate
WO2011140497A3 (en) Method and apparatus for tissue grafting and copying
WO2012149480A3 (en) Systems and methods for in vitro and in vivo imaging of cells on a substrate
WO2008055224A3 (en) Lithium stimulation of cord blood stem cell proliferation and growth factor production
WO2007035843A3 (en) Methods and compositions for organ and tissue functionality
WO2007005828A3 (en) Cell growth and cell transplant devices for gene therapy
WO2006101548A3 (en) Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
WO2012040643A3 (en) Percutaneously deliverable heart or blood vessel valve with frame having abluminally situated tissue membrane
WO2006071794A3 (en) Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
WO2008056368A3 (en) Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
WO2016126340A3 (en) Methods, compositions, and systems for device implantation
EP2338982A3 (en) Postpartum cells derived from umbilical cord tissue and methods of making and using the same
WO2012170340A3 (en) Insertable neural probe with flexible structure
WO2003076604A3 (en) Surgical device for skin therapy or testing
CN101856517B (en) Tissue engineering material-based culture method and applications of melanophore
WO2009126766A3 (en) Medical devices with an interlocking coating and methods of making the same
WO2009131752A3 (en) Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
WO2005086849A3 (en) Implant scaffold combined with autologous or allogenic tissue
WO2010105728A3 (en) Active retinal implant
DE602006014814D1 (en) MATERIALS AND METHOD FOR CHANGING AN IMMUNE RESPONSE TO EXOGENOUS AND ENDOGENOUS IMMUNOGENES, INCLUDING GENIDENTIAL AND NON-GENIDENTIAL CELLS, TISSUE OR ORGANS
WO2008058163A3 (en) Implants and procedures for treatment of pelvic floor disorders
WO2010144678A3 (en) Generation of vascularized human heart tissue and uses thereof
EP2608797A4 (en) Bone marrow derived cd271 precursor cells for cardiac repair

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11807411

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2013519773

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2011807411

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2011279250

Country of ref document: AU

Date of ref document: 20110712

Kind code of ref document: A